High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy
出版年份 2015 全文链接
标题
High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy
作者
关键词
KPNA2, Upper tract urothelial carcinoma, Prognosis, Bladder recurrence
出版物
BMC CANCER
Volume 15, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-05-08
DOI
10.1186/s12885-015-1369-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update
- (2013) Morgan Rouprêt et al. EUROPEAN UROLOGY
- Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making Tool
- (2013) Evanguelos Xylinas et al. EUROPEAN UROLOGY
- Improving the TNM classification: Findings from a 10-year continuous literature review
- (2013) Colleen Webber et al. INTERNATIONAL JOURNAL OF CANCER
- Pattern and risk factors of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: A large Chinese center experience
- (2013) Dong Fang et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy
- (2013) Katharina Grupp et al. MODERN PATHOLOGY
- Multifocal Carcinoma In Situ of the Upper Tract Is Associated With High Risk of Bladder Cancer Recurrence
- (2012) Evanguelos Xylinas et al. EUROPEAN UROLOGY
- Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature
- (2012) Giovanni Lughezzani et al. EUROPEAN UROLOGY
- The Predictive Value of C-reactive Protein for Prognosis in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy: A Multi-institutional Study
- (2012) Nobuyuki Tanaka et al. EUROPEAN UROLOGY
- Quantitative Proteomics Reveals Regulation of Karyopherin Subunit Alpha-2 (KPNA2) and Its Potential Novel Cargo Proteins in Nonsmall Cell Lung Cancer
- (2012) Chun-I Wang et al. MOLECULAR & CELLULAR PROTEOMICS
- Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma
- (2012) Kwang Hyun Kim et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Upper urinary tract transitional cell carcinoma: location is not correlated with prognosis
- (2011) Bogomir Milojevic et al. BJU INTERNATIONAL
- High Expression of Karyopherin-α2 Defines Poor Prognosis in Non–Muscle-Invasive Bladder Cancer and in Patients with Invasive Bladder Cancer Undergoing Radical Cystectomy
- (2011) Jørgen Bjerggaard Jensen et al. EUROPEAN UROLOGY
- EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
- (2011) Marko Babjuk et al. EUROPEAN UROLOGY
- Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro
- (2011) E Noetzel et al. ONCOGENE
- Nuclear factor-κB activation predicts an unfavourable outcome in human upper urinary tract urothelial carcinoma
- (2010) Hsin-Chih Yeh et al. BJU INTERNATIONAL
- Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome
- (2010) Chun-I. Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpression of Karyopherin-2 in Epithelial Ovarian Cancer and Correlation With Poor Prognosis
- (2010) Min Zheng et al. OBSTETRICS AND GYNECOLOGY
- Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration
- (2009) Vitaly Margulis et al. CANCER
- Significant Predictive Factors for Prognosis of Primary Upper Urinary Tract Cancer after Radical Nephroureterectomy in Taiwanese Patients
- (2008) Ching-Chia Li et al. EUROPEAN UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More